Table 2.
Hypoxaemia (19) | TM (42) | Retinal (9) | Oral (260) | Finger-nose (3) | Gait (5) | |
Glasses | 7 | 22 | 6 | 145* | 1 | 1 |
Dental | 9 | 14 | 5 | 82* | 1 | 4* |
Swollen joints | 3 | 14 | 4 | 85* | 3* | 4* |
Hearing | 5 | 17 | 4 | 72* | 2 | 3 |
FH diabetes | 2 | 7 | 2 | 41 | 0 | 1 |
FH high BP | 0 | 6 | 2 | 31** | 0 | 0 |
Tobacco | 3 | 3 | 0 | 27 | 1 | 0 |
Difficulty walking | 3 | 5 | 3* | 36* | 3* | 1 |
High BP | 0 | 5 | 1 | 30 | 0 | 0 |
Diabetes | 0 | 4 | 0 | 23 | 0 | 0 |
High BP Rx | 0 | 4 | 1 | 24* | 0 | 0 |
Asthma | 3 | 3 | 0 | 15 | 1 | 0 |
Smoking | 4* | 1 | 0 | 13 | 0 | 1 |
FH cardiac | 0 | 2 | 0 | 7 | 0 | 0 |
Cardiac Rx | 1 | 1 | 1 | 8* | 0 | 0 |
Cardiovascular | 0 | 1 | 1 | 4 | 0 | 0 |
Low BP | 0 | 0 | 0 | 3 | 0 | 0 |
FH stroke | 0 | 1 | 0 | 2 | 0 | 0 |
FH eye disease | 0 | 0 | 0 | 3 | 0 | 0 |
Heart attack | 0 | 0 | 0 | 3 | 0 | 0 |
Coronary bypass | 0 | 0 | 0 | 3 | 0 | 0 |
Drinking | 0 | 0 | 0 | 1 | 0 | 0 |
Eye treatment | 0 | 0 | 0 | 2 | 0 | 0 |
Memory loss | 0 | 0 | 0 | 2 | 0 | 0 |
Ear treatment | 0 | 1 | 0 | 1 | 0 | 0 |
FH ear disease | 0 | 0 | 0 | 1 | 0 | 0 |
Total populations, in parentheses, reflect the number of subjects with the particular condition in that column identified by technology-enabled screenings. Multiple subjects were associated with more than one condition or questionnaire response.
*P<0.05, subjects are more likely to have responded yes to the column’s question and have the condition.
**P<0.05, subjects are less likely to have responded yes to the column’s question and have the condition.
BP, blood pressure; FH, family history; TM, tympanic membrane; Rx, prescription;